What is IgG4-Related Disease?
IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory autoimmune disorder characterized by elevated serum IgG4 levels, dense infiltration of IgG4-positive plasma cells in affected organs, storiform fibrosis, and typically a favorable response to glucocorticoid therapy 1, 2, 3.
Core Disease Characteristics
IgG4-RD is a relatively newly recognized entity (first described comprehensively in 2003) that can affect virtually any organ system, either simultaneously or sequentially over time 3, 4. The disease predominantly affects older men and presents with:
- Organ enlargement or pseudotumor formation - swelling, nodules, or wall thickening on imaging
- Elevated serum IgG4 levels - though not universally present
- Characteristic histopathology including:
- Dense lymphoplasmacytic infiltration with abundant IgG4-positive plasma cells
- Storiform (cartwheel-like) fibrosis pattern
- Obliterative phlebitis (inflammation and destruction of veins)
- Multi-organ involvement - can occur simultaneously or develop metachronously 3, 4
Pathophysiology
The disease involves an autoantigen-triggered immune response with Th2 predominance, leading to increased production of cytokines (IL-4, IL-5, IL-10, IL-13, TGF-β). IL-10 and TGF-β from regulatory T cells induce B cell switching to IgG4-producing plasma cells and progressive fibrosis, respectively 3. Whether IgG4 itself is pathogenic or protective remains unclear 4.
Common Clinical Manifestations
The disease can affect nearly every organ, with well-established presentations including:
- Pancreato-hepatobiliary: Autoimmune pancreatitis, sclerosing cholangitis
- Glandular: Lacrimal and salivary gland enlargement (Mikulicz's disease)
- Respiratory: Lung nodules, interstitial disease
- Renal: Interstitial nephritis
- Retroperitoneal: Retroperitoneal fibrosis
- Vascular: Aortitis and other vascular involvement
- Head and neck: Orbital pseudotumor, rarely laryngeal involvement 5, 4, 6
Disease Phenotypes
Two distinct phenotypes exist: an inflammatory phenotype and a fibrotic phenotype 1. The fibrotic phenotype is associated with treatment resistance, multiple strictures, multi-organ involvement, and higher relapse rates, particularly when perihilar and intrahepatic bile ducts are involved 5.
Diagnostic Approach
Diagnosis integrates multiple elements:
- Clinical recognition of typical organ involvement patterns
- Imaging findings showing characteristic enlargement, nodules, or wall thickening
- Serological markers - elevated serum IgG4 (though not diagnostic alone), polyclonal gammopathy, complement consumption 7
- Histopathological confirmation via organ biopsy showing the characteristic triad
- Exclusion of mimickers - particularly malignancy and other inflammatory conditions 1, 2
The 2019 ACR/EULAR classification criteria provide a framework with high sensitivity and specificity, though they were designed for classification rather than diagnosis 2, 3.
Critical Diagnostic Pitfall
Distinguishing IgG4-RD from malignancy is essential - the pseudotumor formation can closely mimic cancer, and patients with IgG4-RD may have increased malignancy risk during long-term follow-up 3, 4.
Natural History and Prognosis
While initially considered reversible with good prognosis, long-term disease can lead to irreversible organ dysfunction from end-stage fibrosis (pancreatic failure, renal failure, biliary cirrhosis) 1, 2, 7. Early recognition and treatment are crucial to prevent permanent organ damage. Relapses are common, occurring in approximately 30% of patients during steroid tapering or after withdrawal 5.
Treatment Principles
Glucocorticoids remain first-line therapy, inducing remission in >90% of patients 7. However, the treatment paradigm is evolving toward glucocorticoid-sparing approaches given long-term steroid toxicity 1. B-cell depletion therapy, particularly with rituximab and newer agents like inebilizumab, represents an important advance for steroid-resistant or steroid-dependent patients 1, 3.